Merlin Biomed
North America, New York, United States, New York
Description
Network Solutions - Original domain name registration and reservation services with variety of internet-related business offerings.
Investor Profile
Merlin Biomed has backed more than 18 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series D, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Canada.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series Unknown (33%)
- Series D (28%)
- Series C (17%)
- Series E (11%)
- Series B (6%)
- Post Ipo Equity (6%)
Country Focus
- United States (83%)
- United Kingdom (11%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (6%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Biopharma
- Medical
- Oncology
- Information Technology
- Medical Device
- Developer Tools
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Merlin Biomed frequently co-invest with?
What are some of recent deals done by Merlin Biomed?
Find More Investors Like Merlin Biomed
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
